Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Q2 Revenues Jump 38 Percent, Earnings Climb 48 Percent

NEW YORK, July 27 (GenomeWeb News) - Molecular Devices yesterday reported increased revenues and earnings for the second quarter of 2005.

 

Revenues for the quarter were $44.5 million, up 38 percent over last year's revenues for the same period, which were $32.2 million.

 

Research and development expenses rose to $6.3 million, from $4.7 million during the year-ago period.

 

The firm's net income rose to $3.7 million, or $.22 per share, a 48-percent increase over last year's $2.5 million, or $.17 per share.

 

As of June 30, Molecular Devices had $12.5 million in cash and cash equivalents.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.